Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAAL: Amlodipine and Atorvastatin in Angina
NCT00159718Phase 4Completed
- Sponsor
- Viatris
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 4, randomised, double-blind trial of amlodipine and atorvastatin in coronary artery disease (CAD) and angina pectoris (3 arms), sponsored by Viatris. Primary endpoint: Number of ischemic episodes at 26 weeks. Started Jul 2001; status: completed.
02
Drugs
amlodipineatorvastatin
03
Conditions
coronary artery disease (CAD)angina pectoris
Beyond the preview
Go deeper on NCT00159718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159718.